Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.
L. Boyanova  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Herpes zoster in non-hospitalized children
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Public health significance of invasive mosquitoes in Europe
Comparison of multiple typing methods for Aspergillus fumigatus
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
An eye-catching acanthocephalan
Environmental surveillance and other control measures in the prevention of nosocomial fungal infections  P. Muñoz, A. Burillo, E. Bouza  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective  J.A. Otter, P. Burgess,
Training for the infectious diseases speciality in Norway
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients—implications for treatment  L. Pettersson,
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
M. Or, M. Samish, T. Waner, S. Harrus 
Aerococcus: an increasingly acknowledged human pathogen
G. Kronvall  Clinical Microbiology and Infection 
Elements of design: the knowledge on which we build
Environmental stress and evolvability in microbial systems
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
High serum neopterin and low cytokine values may indicate a non-bacterial etiology for fever of unknown origin in neutropenic patients  Per Engervall,
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals  H. von.
U. Sagel, R.T. Mikolajczyk, A. Krämer 
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
A. Bryskier  Clinical Microbiology and Infection 
H. Sadeghi, D.E.T. Shepherd, D.M. Espino  Osteoarthritis and Cartilage 
Abstracts cont. Clinical Microbiology and Infection
Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.
Benchmarking inappropriate empirical antibiotic treatment
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Fibronectin concentrations in catheter sepsis
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
An after-hours clinical liaison blood culture service—is it worth it?
Training in infectious diseases—looking to the future
Clinical Microbiology and Infection
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain  J.-Y. Wang, H.-L.
J.L. Balcázar  Clinical Microbiology and Infection 
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Brooks A. Keel, Ph.D., H.C.L.D.(A.B.B.)  Fertility and Sterility 
Assessment of the BacT/Alert blood culture system: rapid bacteremia diagnosis with loading throughout the 24 h  Jonas Bengtsson, Martin Wahl, Peter Larsson 
Presentation transcript:

Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents  A.H. Diacon, J.S. Maritz, A. Venter, P.D. van Helden, R. Dawson, P.R. Donald  Clinical Microbiology and Infection  Volume 18, Issue 7, Pages 711-717 (July 2012) DOI: 10.1111/j.1469-0691.2011.03626.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Correlation of individual logCFU and TTP. (a) 2198 matched pairs of logCFU and TTP with a linear correlation coefficient of r = −0.72. There is considerable scatter, which is due to error variation of the measurements (SD for TTP, 50.44; for logCFU, 1.088). (b) Plot of mean TTP against mean logCFU values calculated by grouping logCFU in ranges <3, 3-4, 4-5, 5-6, 6-7, >7 and obtaining the means of logCFU and TTP of values corresponding to these logCFU ranges. The colour coding indicates different studies. Clinical Microbiology and Infection 2012 18, 711-717DOI: (10.1111/j.1469-0691.2011.03626.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Correlation of individual EBAs. This figure shows 224 individual EBA values for day 0-7 plotted against each other. EBA(logCFU) and EBA(TTP) are highly correlated with r = 0.649, p <0.0001. The colour coding indicates different studies. Clinical Microbiology and Infection 2012 18, 711-717DOI: (10.1111/j.1469-0691.2011.03626.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Treatment group logCFU and TTP over time. Twenty-two treatment groups are shown. Each pair of graphs shows EBA(logCFU) on the left and EBA(TTP) on the right. The x-axis is scaled with 1 logCFU or with 50 h per tick mark, respectively, and the y-axis 2 days per tick mark. Fourteen-day groups are shown in the first and second columns and 7-day groups in the third column. Bilinear regression lines of logCFU and TTP on days are shown. Clinical Microbiology and Infection 2012 18, 711-717DOI: (10.1111/j.1469-0691.2011.03626.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 4 Discrimination of group EBAs by logCFU and TTP. Treatment means and variation of EBA(logCFU) and EBA(TTP) in hours are calculated and plotted against each other. The error bars are shown with +1.4 × SE limits, which are approximate 84% confidence limits. This has been calculated so that non-overlap of two of these intervals indicates a significant difference at the 95% level. Overlap or non-overlap of these error bars thus indicates how EBA(logCFU) and EBA(TTP) discriminate between treatment means for EBA day 0-2 (left), EBA day 0-7 (middle), and EBA day 0-14 (right). Clinical Microbiology and Infection 2012 18, 711-717DOI: (10.1111/j.1469-0691.2011.03626.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions